ALS20-101 Lentiviral Gene Therapy

· Children's Hospital of Philadelphia

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALS20-101 Lentiviral Gene Therapy, covering 2026-04-15 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: ALS20-101 Lentiviral Gene Therapy for Beta Thalassemia [Phase 1, Phase 2]